Zimmer Biomet (NYSE:ZBH) recently appointed Ellie Humphrey to the newly created position of chief transformation officer, effective Jan. 19.
In the new role, Humphrey will be responsible for connecting key initiatives and implementing a more integrated transformation strategy across the organization. She will report directly to Hanson.
“Ellie’s extensive experience successfully connecting and overseeing global strategic initiatives for multinational corporations will prove invaluable to Zimmer Biomet as we continue to evolve our business to meet the demands of today’s ever-changing healthcare landscape,” president and CEO Bryan Hanson said in a news release. “Her unique insights and deep industry expertise are critical as we continue to drive growth and work to advance our mission to alleviate pain and improve the quality of life for people around the world.”
Prior to joining the company, Humphrey held several leadership roles at Medtronic, including VP of enterprise excellence and business transformation. She has also held numerous leadership roles at McKinsey & Co.